Gadolinium chelates in angiography and interventional radiology: A useful alternative to iodinated contrast media for angiography

被引:97
作者
Spinosa, DJ
Kaufmann, JA
Hartwell, GD
机构
[1] Univ Virginia, Hlth Syst, Dept Radiol, Charlottesville, VA 22908 USA
[2] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Dept Radiol, Portland, OR 97201 USA
关键词
angiography; contrast media; complications; effects; toxicity; gadolinium; iodine and iodine compounds; uremia;
D O I
10.1148/radiol.2232010742
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gadolinium has physical properties that are well suited for radiographic imaging. Digital subtraction angiography with a gadolinium chelate as contrast medium can provide images of suitable quality for diagnosis and intervention. The overall safety profile of gadolinium-based contrast media is excellent. In particular, these contrast media are well tolerated in patients with renal insufficiency when administered intraarterially in doses of less than 0.3-0.4 mmol per kilogram body weight, with a decreased incidence of contrast medium-induced nephropathy, as compared with similar volumes of iodinated contrast material. The currently available formulations of gadolinium chelates can be injected safely into every arterial and venous structure. However, substantial data are lacking on the intraarterial use of gadolinium in patients with renal insufficiency, particularly at doses that exceed those routinely used in magnetic resonance angiography. Gadolinium chelates in appropriate volumes are useful alternative contrast media in selected high-risk patients undergoing angiographic studies.((C)) RSNA, 2002.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 63 条
[1]  
*AM COLL RAD COMM, 1998, MAN CONTR MED, P1
[2]   Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: Retrospective analysis of an initial experience [J].
Arsenault, TM ;
King, BF ;
Marsh, JW ;
Goodman, JA ;
Weaver, AL ;
Wood, CP ;
Ehman, RL .
MAYO CLINIC PROCEEDINGS, 1996, 71 (12) :1150-1154
[3]  
BARRETT BJ, 1994, J AM SOC NEPHROL, V5, P125
[4]   GD-DOTA - EVALUATION OF ITS RENAL TOLERANCE IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
BELLIN, MF ;
DERAY, G ;
ASSOGBA, U ;
AUBERTON, E ;
GHANY, F ;
DIONVOIRIN, E ;
JACOBS, C ;
GRELLET, J .
MAGNETIC RESONANCE IMAGING, 1992, 10 (01) :115-118
[5]   Gadodiamide in renal transplant patients: Effects on renal function and usefulness as a glomerular filtration rate marker [J].
Berg, KJ ;
Lundby, B ;
Reinton, V ;
Nordal, KP ;
Rootwelt, K ;
Smith, HJ .
NEPHRON, 1996, 72 (02) :212-217
[6]   A CLOSER LOOK AT RADIOCONTRAST-INDUCED NEPHROPATHY [J].
BREZIS, M ;
EPSTEIN, FH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (03) :179-181
[7]   THE RELATIONSHIP BETWEEN THERMODYNAMICS AND THE TOXICITY OF GADOLINIUM COMPLEXES [J].
CACHERIS, WP ;
QUAY, SC ;
ROCKLAGE, SM .
MAGNETIC RESONANCE IMAGING, 1990, 8 (04) :467-481
[8]   EXPERIMENTAL AND THEORETICAL X-RAY-IMAGING PERFORMANCE COMPARISON OF IODINE AND LANTHANIDE CONTRAST AGENTS [J].
CARDINAL, HN ;
HOLDSWORTH, DW ;
DRANGOVA, M ;
HOBBS, BB ;
FENSTER, A .
MEDICAL PHYSICS, 1993, 20 (01) :15-31
[9]   CO2 digital subtraction angiography: Potential complications and their prevention [J].
Caridi, JG ;
Hawkins, IF .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1997, 8 (03) :383-391
[10]   MAGNETIC-RESONANCE-IMAGING CONTRAST AGENTS - DESIGN AND PHYSICOCHEMICAL PROPERTIES OF GADODIAMIDE [J].
CHANG, CA .
INVESTIGATIVE RADIOLOGY, 1993, 28 :S21-S27